Vigilant Capital Management, LLC Abbott Laboratories Transaction History

Vigilant Capital Management, LLC

$1.34 Billion
Q2 2023

A detailed history of Vigilant Capital Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Vigilant Capital Management, LLC holds 389,496 shares of ABT stock, worth $51.3 Million. This represents 3.17% of its overall portfolio holdings.

Number of Shares

389,496

Previous 377,947 3.06%

Holding current value

$51.3 Million

Previous $38.3 Million 10.95%

% of portfolio

3.17%

Previous 3.11%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$100.78 - $112.29 $1.16 Million - $1.3 Million	11,549 Added 3.06%	389,496 $42.5 Million
Q1 2023 May 01, 2023	BUY	$96.86 - $114.01 $1.59 Million - $1.87 Million	16,421 Added 4.54%	377,947 $38.3 Million
Q4 2022 Jan 26, 2023	BUY	$95.06 - $111.52 $1.42 Million - $1.67 Million	14,935 Added 4.31%	361,526 $39.7 Million
Q3 2022 Oct 25, 2022	BUY	$96.76 - $112.03 $1.43 Million - $1.66 Million	14,775 Added 4.45%	346,591 $33.5 Million
Q2 2022 Jul 06, 2022	BUY	$102.07 - $123.37 $748,377 - $904,548	7,332 Added 2.26%	331,816 $36.1 Million
Q1 2022 Apr 07, 2022	BUY	$114.02 - $139.04 $1.5 Million - $1.83 Million	13,161 Added 4.23%	324,484 $38.4 Million
Q4 2021 Jan 06, 2022	BUY	$115.53 - $141.46 $1.59 Million - $1.95 Million	13,779 Added 4.63%	311,323 $43.8 Million
Q3 2021 Oct 08, 2021	BUY	$116.66 - $129.06 $851,268 - $941,750	7,297 Added 2.51%	297,544 $35.1 Million
Q2 2021 Jul 09, 2021	BUY	$105.79 - $124.53 $2.01 Million - $2.37 Million	19,033 Added 7.02%	290,247 $33.6 Million
Q1 2021 Apr 16, 2021	BUY	$108.84 - $128.23 $2.11 Million - $2.49 Million	19,399 Added 7.7%	271,214 $32.5 Million
Q4 2020 Jan 14, 2021	BUY	$105.0 - $114.42 $634,095 - $690,982	6,039 Added 2.46%	251,815 $27.6 Million
Q3 2020 Oct 15, 2020	BUY	$91.64 - $111.29 $42,062 - $51,082	459 Added 0.19%	245,776 $26.7 Million
Q2 2020 Jul 10, 2020	SELL	$76.57 - $98.0 $103,369 - $132,300	-1,350 Reduced 0.55%	245,317 $22.4 Million
Q1 2020 Apr 17, 2020	BUY	$62.82 - $91.86 $68,850 - $100,678	1,096 Added 0.45%	246,667 $19.5 Million
Q4 2019 Jan 17, 2020	BUY	$78.51 - $87.4 $193,213 - $215,091	2,461 Added 1.01%	245,571 $21.3 Million
Q3 2019 Oct 16, 2019	SELL	$81.84 - $88.74 $529,259 - $573,881	-6,467 Reduced 2.59%	243,110 $20.3 Million
Q2 2019 Jul 18, 2019	SELL	$72.88 - $85.0 $377,809 - $440,640	-5,184 Reduced 2.03%	249,577 $21 Million
Q1 2019 Apr 09, 2019	SELL	$66.22 - $80.06 $1.62 Million - $1.96 Million	-24,423 Reduced 8.75%	254,761 $20.4 Million
Q4 2018 Jan 15, 2019	SELL	$65.56 - $74.27 $216,675 - $245,462	-3,305 Reduced 1.17%	279,184 $20.2 Million
Q3 2018 Oct 11, 2018	SELL	$60.81 - $73.36 $115,234 - $139,017	-1,895 Reduced 0.67%	282,489 $20.7 Million
Q2 2018 Jul 11, 2018	SELL	$57.57 - $63.54 $49,855 - $55,025	-866 Reduced 0.3%	284,384 $17.3 Million
Q1 2018 Apr 04, 2018	BUY	$56.27 - $63.62 $254,903 - $288,198	4,530 Added 1.61%	285,250 $17.1 Million
Q4 2017 Jan 31, 2018	BUY	$53.68 - $57.47 $2.8 Million - $3 Million	52,164 Added 22.82%	280,720 $16 Million
Q3 2017 Oct 13, 2017	BUY	$48.06 - $53.64 $11 Million - $12.3 Million	228,556	228,556 $12.2 Million

Others Institutions Holding ABT

# of Institutions

3,303

Shares Held

1.34B

Call Options Held

9.84M

Put Options Held

8.59M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $231B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vigilant Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vigilant Capital Management, LLC with notifications on news.

Account

Vigilant Capital Management, LLC Abbott Laboratories Transaction History